Bio Green Med Solution reported Q3 2026 financial results, highlighting a significant increase in fire safety product revenue to $454,000 and a narrowed net loss of $0.4 million. The company also announced that its Form S-4 for the proposed business combination with Future NRG Sdn. Bhd. has been declared effective, with a shareholder vote planned for November 2026.
Term
Q3 2026
“During the third quarter, our fire safety business generated $454,000 in product revenue, compared to $81,000 in the prior-year period, and yielded a gross margin of approximately 25%, while our net loss narrowed to $0.4 million from $1.0 million in the prior-year period.”
Datuk Dr. Doris Wong Sing Ee, Chief Executive Officer and Executive Director
“We also reduced general and administrative expenses by 37% year over year and ended the quarter with $3.5 million in cash and cash equivalents.”
Datuk Dr. Doris Wong Sing Ee, Chief Executive Officer and Executive Director
Bio Green Med Solution, Inc. is undergoing a significant business combination with Future NRG Sdn. Bhd. (FNRG), which will result in FNRG shareholders owning over 99% of the combined company. The company recently deconsolidated its former subsidiary, Cyclacel Limited, following a creditors voluntary liquidation and has pivoted its business focus through various asset sales and exchange agreements.
Bio Green Med Solution Nasdaq/NYSE Compliance Notice
Bio Green Med Solution received a deficiency notice from Nasdaq on October 29, 2026, because its common stock failed to maintain a minimum bid price of $1.00 for 30 consecutive business days. The company has until April 27, 2027, to regain compliance and is considering a reverse stock split as a potential remedy in connection with its pending business combination with Future NRG Sdn. Bhd.
Bio Green Med Solution, Inc. declared a quarterly cash dividend of $0.15 per share on its 6% Convertible Exchangeable Preferred Stock. The dividend is payable on November 1, 2026, to stockholders of record as of October 26, 2026.